Syn-Ake® - natures "botox" reduces dynamic lines + wrinkles

Botox has quickly grown in popularity over the last few years, and has been very effective at reducing the appearance of dynamic lines and wrinkles. Whether you are already getting injections, are not a huge fan of needles or simply don't like the thought of injecting neurotoxins directly into our bodies (botox), there are now topical options proven to reduce the depth of dynamic lines and wrinkles.


botox alternative Syn-Ake topical botox


Dipeptide Diaminobutyroyl Benzylamide Diacetate or Syn-Ake® for short,  achieves it's skin smoothing result by mimicking the effects of waglerin-1, a polypeptide found in snake venom.  Waglerin-1 prevents sodium ion uptake in the muscle encouraging a relaxed state, releasing muscle tension in the tissue and softening the appearance of wrinkles caused by facial movement.  Because Syn-Ake® does not paralyze the muscles at a deeper level like botox, you experience a reduction in wrinkles without the risk of creating a frozen or droopy appearance that may occur with over treatment of an injectable. 

Studies conducted by Pentapharm the creator of Syn-Ake show a reduction in dynamic lines and wrinkles of up to 52% after 28 days of use.

The benefits?

  • up to 52% improvement after 28 days of use
  • reduction in depth of crows feet
  • softens forehead lines + between brows
  • reduction in "smokers" lines (can be used around the mouth/lips)
  • extends life of botox treatments
  • works in unison with botox to extend visible benefit
  • safe for the under eye area

And for an even more effective result...

By combining Syn-Ake with Argireline (Acetyl Hexapeptide-8) which works in a similar fashion, we've created an even more effective wrinkle relaxing duo to soften and minimize dynamic lines and wrinkles.


Find Syn-Ake®, Argireline and many other wonderful anti-agers in BV-9 Platinum Provectus Super Serum with bee venom

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.